The role of p63 and ΔNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis

Human Pathology

Volumn 34, Issue 9, 2003, Pages 850-856

  Geddert, Helene ^b   Kiel, Sibylle ^b   Heep, Hans Jörg ^b   Gabbert, Helmut Erich ^b   Sarbia, Mario ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Barrett's esophagus; Carcinogenesis; P63; Squamous cell carcinoma

Indexed keywords

ISOPROTEIN; PROTEIN P40; PROTEIN P63; CKAP4 PROTEIN, HUMAN; DNA; DNA BINDING PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BASAL CELL; CANCER; CARCINOGENESIS; CONTROLLED STUDY; DELTA NP63 GENE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOGENESIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; FLUORESCENCE DIFFERENTIAL POLYMERASE CHAIN REACTION; GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HIGH GRADE INTRAEPITHELIAL NEOPLASIA; HUMAN; HUMAN TISSUE; LOW GRADE INTRAEPITHELIAL NEOPLASIA; MAJOR CLINICAL STUDY; MALE; METAPLASIA; P40 GENE; P63 GENE; POLYMERASE CHAIN REACTION; PRECANCER; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS LOW GRADE INTRAEPITHELIAL NEOPLASIA; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CARCINOMA IN SITU; CELL COUNT; ENZYME IMMUNOASSAY; ESOPHAGUS TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL COUNT; DNA, NEOPLASM; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0141651992     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00342-3     Document Type: Article

References (31)

1. Irwin MS, Kaelin WG Jr: Role of the newer p53 family proteins in malignancy. Review. Apoptosis 6:17-929, 2001
2. Ratovitski EA, Patturajan M, Hibi K, et al: p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci U S A 98:1817-1822, 2001
3. Hibi K, Trink B, Patturajan M, et al: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 97:5462-5467, 2000
4. Yang A, Kaghad M, Wang Y, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316, 1998
5. Nylander K, Coates PJ, Hall PA: Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 87:368-372, 2000
6. Parsa R, Yang A, McKeon F, et al: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 113:1099-1105, 1999
7. Barbareschi M, Pecciarini L, Cangi MG, et al: p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 25:1054-1060, 2001
8. Chilosi M, Doglioni C: Constitutive p63 expression in airway basal cells. A molecular target in diffuse lung diseases. Review. Sarcoidosis Vasc Diffuse Lung Dis 18:23-26, 2001
9. Di Como CJ, Urist MJ, Babayan I, et al: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501, 2002
10. Signoretti S, Waltregny D, Dilks J, et al: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157:1769-1775, 2000
11. Wang TY, Chen BF, Yang YC, et al: Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. HUM PATHOL 32:479-486, 2001
12. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
13. Glickman JN, Yang A, Shahsafaei A, et al: Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. HUM PATHOL 32:1157-1165, 2001
14. Hall PA, Woodman AC, Campbell SJ, et al: Expression of the p53 homologue p63 alpha and delta Np63 alpha in the neoplastic sequence of Barrett's oesophagus: Correlation with morphology and p53 protein. Gut 49:618-623, 2001
15. Taniere P, Martel-Planche G, Saurin JC, et al: TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 85:721-726, 2001
16. Hamilton SR, Aaltonen LA (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of the Digestive System. Lyon, France, IARC Press, 2000
17. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumors (ed 5). New York, Wiley-Liss, 1997
18. Levin KJ, Appelman HD: Tumors of the esophagus and stomach, in Rosai J, Sobin LH (eds): Atlas of Tumor Pathology, Third Series, Fascicle 18. Washington, DC, Armed Forces Institute of Pathology, 1995
19. Reid BJ, Haggitt RC, Rubin CE, et al: Observer variation in the diagnosis of dysplasia in Barrett's esophagus. HUM PATHOL 19: 166-178, 1988
20. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual (ed 2). New York, Cold Spring Harbor Laboratory, 1989
21. An HX, Beckmann MW, Reifenberger G, et al: Gene amplification and over-expression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol 154:113-118, 1999
22. Crook T, Nicholls JM, Brooks L, et al: High level expression of deltaN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19:3439-3444, 2000
23. Kaufmann O, Fietze E, Mengs J, et al: Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823-830, 2001
24. Ianakiev P, Kilpatrick MW, Toudjarska I, et al: Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 67:59-66, 2000
25. Mills AA, Zheng B, Wang XJ, et al: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713, 1999
26. Yamaguchi K, Wu L, Caballero OL, et al: Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 86:684-689, 2000
27. Redon R, Muller D, Caulee K, et al: A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61:4122-4129, 2001
28. Suliman Y, Opitz OG, Avadhani A, et al: p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Cancer Res 61:6467-6473, 2001
29. Montesano R, Hollstein M, Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review. Int J Cancer 69:225-235, 1996
30. Park BJ, Lee SJ, Kim JI, et al: Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60: 3370-3374, 2000
31. Hibi K, Nakayama H, Taguchi M, et al: AIS over-expression in advanced esophageal cancer. Clin Cancer Res 7:469-472, 2001